Asrt stock forecast.

P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ...Discover historical prices for ASRT stock on Yahoo Finance. View daily, weekly or monthly format back to when Assertio Holdings, Inc. stock was issued.For the current quarter, Assertio is expected to post earnings of $0.13 per share, indicating a change of -35% from the year-ago quarter. The Zacks Consensus Estimate has changed -5% over the last ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Real time Assertio (ASRT) stock price quote, stock graph, news & analysis.

Assertio last announced its earnings data on November 8th, 2023. The reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.08 by $0.09. The firm earned $35.63 million during the quarter, compared to analyst estimates of $49.54 million.Nov 30, 2023 · Assertio Holdings, Inc. (ASRT) share price prediction for 2023, 2024, 2025, 2026 and 2027. ASRT one year forecast. Assertio Holdings stock monthly and weekly forecasts.

Dec 1, 2023 · 3 equities research analysts have issued twelve-month target prices for Cronos Group's shares. Their CRON share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price.

Assertio Therapeutics (ASRT) Stock Forecast & Price TargetFind the latest StoneCo Ltd. (STNE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...487.25K. -88.59%. Get the latest Assertio Holdings Inc (ASRT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...Find real-time RIOT - Riot Platforms Inc stock quotes, company profile, news and forecasts from CNN Business.

Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

The aggregate market value of the shares of common stock held by non‑affiliates of the registrant, computed by reference to the closing price as reported on the Nasdaq Stock Market as of June 30, 2021, the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $ 68.4 million.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Apr 25, 2023 · Assertio and Spectrum to Host Conference Call Today at 8:30 AM ET. LAKE FOREST, Ill., and BOSTON, April 25, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio”), a ... PAA Stock 12 Months Forecast. $16.71. (7.12% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Plains All American in the last 3 months. The average price target is $16.71 with a high forecast of $21.00 and a low forecast of $13.50. The average price target represents a 7.12% change from the last price of $15.60.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comCybin Inc () Stock Market info Recommendations: Buy or sell Cybin stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cybin share forecasts, stock quote and buy / sell signals below.According to present data Cybin's CYBN shares and potentially its market environment have been in a bullish cycle in the …Assertio Holdings, Inc. Common Stock (ASRT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Why Assertio (ASRT) Stock Is Volatile Today benzinga.com - August 7 at 11:38 AM: Industry Analysts Just Upgraded Their Assertio Holdings, Inc. (NASDAQ:ASRT) Revenue Forecasts By 13% finance.yahoo.com - August 6 at 11:55 AM: BWS Financial Keeps Their Buy Rating on Assertio Therapeutics ...View Crescent Point Energy Corporation CPG investment & stock information. Get the latest Crescent Point Energy Corporation CPG detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...The Assertio Therapeutics stock forecast for tomorrow is $ 1.197103, which would represent a 4.10% gain compared to the current price. In the next week, the price of ASRT is expected to decrease by -3.45% and hit $ 1.110339. As far as the long-term Assertio Therapeutics stock forecast is ...

CVNA Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Carvana Co in the last 3 months. The average price target is $37.08 with a high forecast of $60.00 and a low forecast of $24.00. The average price target represents a 15.84% change from the last price of $32.01.

For Assertio Holdings stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Assertio Holdings stock forecast of $0.24, a high forecast of $0.26, and a low forecast of $0.22. The average Assertio Holdings stock forecast 2028 represents a -78.89% decrease from the last price of $1.13999998569489.Find the latest Modiv Industrial, Inc. (MDV) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Apr 17, 2023 · Assertio Holdings, Inc.'s ( NASDAQ:ASRT) price-to-earnings (or "P/E") ratio of 3.2x might make it look like a strong buy right now compared to the market in the United States, where around half of ... Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.The average price target for e.l.f. Beauty is $140.58. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $178.00 ,the lowest forecast is $119.00. The average price target represents 47.84% Increase from the current price of $95.09.Was $400m market cap company issues stock for $200m market cap company and assuming roughly 100m newco shares the stock market is proposing a $250-$300m valuation.Putting a conservative 3x multiple on this revenue stream would place the value of ASRT’s stake in NES at $63 mm (3 x $175 mm x 12%), representing almost $1.5/share in value to ASRT shareholders.The Assertio Therapeutics stock price gained 11.76% on the last trading day (Friday, 1st Dec 2023), rising from $1.02 to $1.14. During the last trading day the stock fluctuated 13.73% from a day low at $1.02 to a day high of $1.16. The price has fallen in 6 of the last 10 days but is still up by 2.7% over the past 2 weeks.

Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy

Dec 1, 2023 · 3 equities research analysts have issued twelve-month target prices for Cronos Group's shares. Their CRON share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price.

Wrap Technologies' stock was trading at $1.69 at the start of the year. Since then, WRAP shares have increased by 62.7% and is now trading at $2.75. View the best growth stocks for 2023 here.CRON Stock 12 Months Forecast. $2.51. (34.95% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cronos Group in the last 3 months. The average price target is $2.51 with a high forecast of $3.66 and a low forecast of $1.55. The average price target represents a 34.95% change from the last price of $1.86.Assertio Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ASRT updated stock price target summary. Sep 12, 2023 · This year the stock has moved from a high of $8.01 to a low of $2.07. Given its current price of $3.05, we currently rate Assertio a strong buy and believe it could double. Buying the hype in ASRT ... Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript Reported EPS is $-0.46 EPS, expectations were $0.23. Operator: Good morning and welcome to the …Dec 1, 2023 · 3 equities research analysts have issued twelve-month target prices for Cronos Group's shares. Their CRON share price targets range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price. With Cbak Energy Technology stock trading at $0.79 per share, the total value of Cbak Energy Technology stock (market capitalization) is $70.68M. Cbak Energy Technology stock was originally listed at a price of $26.50 in Feb 14, 2005. If you had invested in Cbak Energy Technology stock at $26.50, your return over the last 18 years would have ...ASRT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.08 -- higher than only 2.12% of US-listed equities with positive expected earnings growth. The price/operating cash flow metric for ASSERTIO HOLDINGS INC is higher than just 4.73% of stocks in our set with a positive cash flow.Mar 1, 2023 · Assertio Holdings' estimated fair value is US$7.75 based on 2 Stage Free Cash Flow to Equity. Assertio Holdings' US$5.53 share price signals that it might be 29% undervalued. Our fair value ... Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Aclaris Therapeutics Inc have a median target of 5.50, with a high estimate of 27.00 and a low estimate of 1.00. The ...Based on 4 Wall Street analysts offering 12 month price targets for Arbor Realty in the last 3 months. The average price target is $15.75 with a high forecast of $19.00 and a low forecast of $12.50. The average price target represents a 26.00% change from the last price of $12.50. Highest Price Target $19.00. Average Price Target $15.75.Stock Price Forecast The 18 analysts offering 12-month price forecasts for Plains All American Pipeline LP have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 13.50.Assertio Holdings, Inc. - Sell. Zacks' proprietary data indicates that Assertio Holdings, Inc. is currently rated as a Zacks Rank 4 and we are expecting a below average return from the ASRT shares ...Instagram:https://instagram. vigrx stockbest us forex broker mt4ai for stockswindows server courses Assertio Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ASRT updated stock price target summary.Durect Corp. analyst ratings, historical stock prices, earnings estimates & actuals. DRRX updated stock price target summary. paper trading account webullbest apps to track stocks Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2023 Earnings Call Transcript Reported EPS is $-0.46 EPS, expectations were $0.23. Operator: Good morning and welcome to the Assertio Holdings Inc. freq Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyAssertio is a leading commercial pharmaceutical company bringing differentiated products to patients and has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. The Company has grown through business development including licensing, mergers, and acquisitions and is interested in ...